MedTech News
.................... by Andrew Celentano
AI-powered electrocardiogram detects early signs of heart failure
Interpreting relatively inexpensive electrocardiograms (ECGs) with an artificial intelligence (AI) algorithm accurately screened patients for a key precursor of heart failure in Kenya.
Brain imaging reveals migraine headache subtypes
They’ve been described as “brain on fire” or “an ice pick through the head.” Migraine headaches affect more than one in 10 Americans, and they’re so much worse than a regular headache.
Specialized RNA molecules could counter ALS neurodegeneration
Misshapen proteins cause a mess of trouble—particularly in neurodegenerative diseases. But a new study suggests it’s possible that giving them a little bit of extra support could keep them working correctly, and even reverse the damage they have caused.
Gold-coated microneedles can detect subtleties in how liver and kidneys process drugs in real time
Scientists have taken a giant leap forward with the development of tiny microneedles designed to detect subtle but critical changes in how the liver and kidneys process therapeutic drugs.
This Substance Is 1,000 Times More Potent Than the World’s Spiciest Pepper — and It Could Provide Pain Relief
Capsaicin, the toxin found in chili peppers, is what many people believe to be the spiciest chemical on Earth. But an ultrapotent form of this chemical made by an unassuming cactus-like plant makes typical capsaicin seem mild in comparison.
FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction
The approval of Bright Uro’s Glean abdominal sensor advances the capabilities of its broader Glean urodynamics system that gained FDA approval in March 2025.
FDA greenlights Rivanna’s AI musculoskeletal imaging system
With FDA clearance in hand, Rivanna highlighted that it will accelerate the development of further AI capabilities for the Accuro XV system.
Nerve-sprouting therapy boosts coordinated walking across spinal cord injury severities in mice
A research group led by Professor Dr. Dietmar Fischer from the Institute of Pharmacology II at University Hospital Cologne is therefore pursuing a new approach to treating such contusion injuries.